タンパク質合成の調査レビュー：2024年

世界の商用アミノ酸の市場規模は、2024年の318億米ドルから、予測期間中はCAGR 6.1%で推移し、2029年には428億米ドルに成長すると予測されています。

世界の組換えタンパク質の市場規模は、2024年の1,418億米ドルから、予測期間中はCAGR 7.5%で推移し、2029年には2,036億米ドルに成長すると予測されています。

世界のPEG化タンパク質の市場規模は、2023年の102億米ドルから、予測期間中はCAGR 9.4%で推移し、2028年には159億米ドルに成長すると予測されています。

タンパク質合成は、すべての生物にとって不可欠であり、細胞が生存し機能するために必要なタンパク質を生産することを可能にします。これは、細胞内でタンパク質を構築する基本的な生物学的プロセスであり、あらゆる細胞機能に不可欠です。タンパク質合成の主要成分は、デオキシリボ核酸 (DNA)、リボ核酸 (RNA)、リボソーム、アミノ酸です。

慢性疾患の増加によるタンパク質治療薬への需要の高まりが、この市場を牽引する主な要因です。また、効率と生産性を高める無細胞システムや改良型発現ベクターの進歩も、タンパク質合成市場を後押ししています。無細胞システム、ハイスループット技術、個別化医療への注力に向けた新興国市場の発展も、タンパク質合成市場の成長の主な要因となっています。高い生産コストと複雑な技術は市場の成長に影響を与えます。

当調査レビューは、BCC Researchが2024年に発行した商用アミノ酸、組み換えタンパク質、オリゴヌクレオチド、ペプチド化タンパク質、ペプチド合成に関するレポートのハイライトと抜粋を含み、それぞれの市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 序文

第2章 商用アミノ酸 (BIO007N)

• 市場見通し
• 調査範囲
• 市場サマリー
• 市場概要
• 商業上の利益
• 化学構造
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場の課題
• 市場機会
• 規制構造
• 世界規制枠組み
• さまざまな用途に対する規制要件
• 品質管理と製造基準
• 新興技術と開発
• 代謝工学と合成生物学
• ハイスループットスクリーニングと発酵最適化
• 常用フローバイオ触媒
• 高度なクロマトグラフィー技術
• ヒドロキシアミノ酸
• グリーンケミストリーと持続可能な生産
• 主要な市場動向
• 商用アミノ酸：世界市場
• 商用アミノ酸市場：製品タイプ別
• メチオニン
• リジン
• トレオニン
• トリプトファン
• フェニルアラニン
• グルタミン酸
• システイン
• アスパラギン酸
• グリシン
• アラニン
• アルギニン
• プロリン
• ロイシン
• バリン
• チロシン
• その他
• 商用アミノ酸市場：用途別
• 動物飼料
• 食品香料
• 特殊用途
• 商用アミノ酸市場：地域別
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 世界のその他の地域
• 商用アミノ酸の持続可能性：ESGの観点
• ESG：イントロダクション
• 商用アミノ酸市場における持続可能性
• ESGデータの理解

第3章 世界の組み換えタンパク質市場 (BIO254A)

• 市場見通し
• 調査範囲
• 市場サマリー
• 市場概要
• 発現宿主システムの種類
• 組み換えタンパク質の作用機序
• 組み換えタンパク質生産における一般的な手順
• 組み換えタンパク質の市場力学
• 促進要因
• 抑制要因
• 機会
• 組み換えタンパク質の新たな技術と開発
• タンパク質工学の進歩
• CRISPRゲノム編集
• 無細胞タンパク質合成
• 世界の組み換えタンパク質市場：製品タイプ別
• ホルモン
• サイトカイン
• 酵素
• 抗体
• 抗原
• その他
• 世界の組み換えタンパク質市場：宿主細胞タイプ別
• 細菌宿主細胞
• 酵母と真菌細胞
• 哺乳類細胞
• 昆虫細胞
• その他
• 世界の組み換えタンパク質市場：用途別
• 治療薬・ワクチン
• 生物医療研究
• 診断
• 世界の組み換えタンパク質市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域
• 組み換えタンパク質市場における持続可能性
• ESGデータの理解
• ESGパフォーマンス分析
• 総論

第4章 オリゴヌクレオチド：世界市場 (BIO220B)

• 市場見通し
• 調査範囲
• 市場分析
• 市場概要
• オリゴヌクレオチド合成の歴史
• オリゴヌクレオチドの種類
• オリゴヌクレオチド合成の代替形態
• 合成オリゴヌクレオチドの多彩な機能
• オリゴ治療薬の規制経路
• 動物モデルと研究
• 規制当局の役割
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場における機会
• さまざまな分野での新たな応用
• オリゴヌクレオチドの新たな技術と開発
• DNA合成装置
• 新興技術
• 世界のオリゴヌクレオチド合成市場：製品タイプ別
• オリゴヌクレオチド医薬品
• 機器・試薬
• 合成オリゴ
• サービス
• 世界のオリゴヌクレオチド合成市場：用途別
• 研究
• 診断・治療
• 世界のオリゴヌクレオチド合成市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域
• オリゴヌクレオチド市場におけるESGの動向
• ESG：イントロダクション
• オリゴヌクレオチド製造プロセスの持続可能性の評価
• 市場におけるESGパフォーマンス
• 総論

第5章 PEG化タンパク質市場 (BIO253A)

• 市場見通し
• 調査範囲
• 市場サマリー
• 市場概要
• タンパク質PEG化の利点
• PEG化治療薬の限界
• PEG化タンパク質の市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 新興技術と開発
• 非共有結合性PEG化
• ナノ粒子のPEG化
• 抗体薬物複合体 (ADC)
• 世界のPEG化タンパク質市場：タンパク質タイプ別
• 顆粒球コロニー刺激因子 (G-CSF)
• PEG化モノクローナル抗体
• ペグ化インターフェロン
• PEG化組み換え因子
• その他
• 世界のPEG化タンパク質市場：PEG化タイプ別
• 直鎖PEG化タンパク質
• 分岐PEG化タンパク質
• 世界のPEG化タンパク質市場：PEG化用途別
• 自己免疫疾患
• 血液疾患
• 癌
• その他
• 世界のPEG化タンパク質市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域
• PEG化タンパク質市場における持続可能性：ESGの観点
• ESG：イントロダクション
• PEG化タンパク質産業における持続可能性
• ESGデータの理解
• ESGパフォーマンス分析
• 総論

第6章 ペプチド合成：世界市場 (BIO252A)

• 市場見通し
• 調査範囲
• 市場サマリー
• ペプチド治療：市場概要
• ペプチドの重要性
• ペプチド合成
• ペプチド治療の動向
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• ペプチド合成と治療薬製造のための新技術
• 水性媒体におけるSPPSの進歩
• 化学合成
• ペプチドドラッグデリバリー
• 新開発事例：企業別
• セグメント別市場分析
• 世界のペプチド合成市場：ペプチドタイプ別
• 合成ペプチド
• 抗菌ペプチド
• ホルモンペプチド
• 生理活性ペプチド
• コラーゲンペプチド
• その他
• 世界のペプチド合成市場：用途別
• ペプチド治療
• 化粧品
• 栄養補助食品
• その他
• 世界のペプチド合成市場：合成タイプ別
• 固相
• 液相
• ハイブリッド
• 世界のペプチド合成市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域
• ペプチド合成産業における持続可能性：ESGの観点
• ペプチド治療薬メーカーのESGの重要性
• ペプチド治療薬メーカーのESGの実践
• BCCの見解

第7章 付録

List of Tables

• Table 1 : Global Commercial Amino Acids Market, by Application, Through 2029
• Table 2 : Commercial Amino Acids, by Use
• Table 3 : Protein Amino Acids
• Table 4 : Applications of Selected Amino Acids
• Table 5 : Global Commercial Amino Acids Market, Through 2029
• Table 6 : Leading Global Producers of Amino Acids, by Product Type, 2023
• Table 7 : Global Commercial Amino Acids Market, by Product Type, Through 2029
• Table 8 : Methionine Content of Selected Foods
• Table 9 : Global Commercial Amino Acids Market, by Application, Through 2029
• Table 10 : Global Commercial Amino Acids Market, by Region, Through 2029
• Table 11 : North American Commercial Amino Acids Market, by Country, Through 2029
• Table 12 : European Commercial Amino Acids Market, by Country, Through 2029
• Table 13 : Asia-Pacific Commercial Amino Acids Market, by Country, Through 2029
• Table 14 : LATAM Commercial Amino Acids Market, by Country, Through 2029
• Table 15 : RoW Commercial Amino Acids Market, by Application, Through 2029
• Table 16 : ESG Rankings for Major Commercial Amino Acids Companies, 2024*
• Table 17 : Global Market for Recombinant Proteins, by Region, Through 2029
• Table 18 : Comparison of Different Protein Expression Host Systems
• Table 19 : R&D Expenditures of Key Biopharmaceutical Companies, 2023
• Table 20 : Global Market for Recombinant Proteins, by Product Type, Through 2029
• Table 21 : Global Market for Recombinant Proteins, by Host Cell Type, Through 2029
• Table 22 : Global Market for Recombinant Proteins, by Application, Through 2029
• Table 23 : Therapeutic Applications of Recombinant Proteins, by Product Type
• Table 24 : Global Market for Recombinant Proteins, by Region, Through 2029
• Table 25 : North American Market for Recombinant Proteins, by Country, Through 2029
• Table 26 : European Market for Recombinant Proteins, by Country, Through 2029
• Table 27 : Asia-Pacific Market for Recombinant Proteins, by Country, Through 2029
• Table 28 : ESG Rankings for Major Recombinant Protein Drug Companies, 2024*
• Table 29 : ESG: Environmental Overview
• Table 30 : ESG: Social Factors Overview
• Table 31 : ESG: Governance Overview
• Table 32 : Global Market for Oligonucleotides, by Region, Through 2028
• Table 33 : Comparison of Oligonucleotide and Polynucleotide
• Table 34 : List of Approved Oligonucleotide Therapeutics, 2023
• Table 35 : Global Market for Oligonucleotide Synthesis, by Product Type, Through 2028
• Table 36 : Revenue Generated, by Few Oligonucleotide Drugs, 2022
• Table 37 : Global Market for Oligonucleotide Synthesis, by Application, Through 2028
• Table 38 : Global Market for Oligonucleotide Synthesis, by Region, Through 2028
• Table 39 : North American Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 40 : European Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 41 : Asia-Pacific Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 42 : Assessment of the Oligonucleotide Manufacturing Process Against the 12 Principles of Green Chemistry
• Table 43 : Key Focus Areas in ESG Metrics
• Table 44 : ESG Rankings for Oligonucleotide Companies, 2023*
• Table 45 : Global Market for PEGylated Proteins, by Region, Through 2028
• Table 46 : PEGylated Drugs in Clinical Trials for Cancer
• Table 47 : Discontinued PEGylated Drugs in Clinical Trials
• Table 48 : Side Effects Observed with Approved Products
• Table 49 : Global Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 50 : Marketed PEGylated G-CSF Drugs
• Table 51 : Global Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 52 : Global Market for PEGylated Proteins, by Application, Through 2028
• Table 53 : Global Market for PEGylated Proteins, by Region, Through 2028
• Table 54 : North American Market for PEGylated Proteins, by Country, Through 2028
• Table 55 : North American Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 56 : North American Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 57 : North American Market for PEGylated Proteins, by Application, Through 2028
• Table 58 : European Market for PEGylated Proteins, by Country, Through 2028
• Table 59 : European Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 60 : European Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 61 : European Market for PEGylated Proteins, by Application, Through 2028
• Table 62 : Asia-Pacific Market for PEGylated Proteins, by Country, Through 2028
• Table 63 : Asia-Pacific Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 64 : Asia-Pacific Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 65 : Asia-Pacific Market for PEGylated Proteins, by Application, Through 2028
• Table 66 : RoW Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 67 : RoW Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 68 : RoW Market for PEGylated Proteins, by Application, Through 2028
• Table 69 : ESG Risk Rankings for Major PEGylated Protein Drug Companies, 2024*
• Table 70 : ESG: Environmental Overview
• Table 71 : ESG: Social Overview
• Table 72 : ESG: Governance Overview
• Table 73 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 74 : Pros and Cons of Liquid Phase and Solid Phase Synthesis
• Table 75 : Global Cancer Incidence, 2020
• Table 76 : Emerging Trends in Peptide Synthesis Technologies
• Table 77 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 78 : Global Market for Peptide Synthesis, by Application, Through 2028
• Table 79 : Peptide-based Drugs Approved by FDA in 2021
• Table 80 : Best-Selling Peptide Therapeutics, 1982-2021
• Table 81 : Global Market for Peptide Synthesis, by Synthesis Type, Through 2028
• Table 82 : Global Market for Peptide Synthesis, by Region, Through 2028
• Table 83 : North American Market for Peptide Synthesis, by Country, Through 2028
• Table 84 : European Market for Peptide Synthesis, by Country, Through 2028
• Table 85 : Asia-Pacific Market for Peptide Synthesis, by Country, Through 2028
• Table 86 : RoW Market for Peptide Synthesis, by Country, Through 2028
• Table 87 : Role of ESG in Environmental Performance
• Table 88 : Role of ESG in Social Performance
• Table 89 : Role of ESG in Governance Performance
• Table 90 : ESG Rankings for Major Peptide Therapeutics Companies, 2023*

List of Figures

• Figure 1 : Snapshot of the Market Dynamics for Commercial Amino Acids
• Figure 2 : Global Commercial Amino Acids Market Share, by Product Type, 2023
• Figure 3 : Global Commercial Amino Acids Market Share, by Application, 2023
• Figure 4 : Global Commercial Amino Acids Market Share, by Region, 2023
• Figure 5 : North American Commercial Amino Acids Market Share, by Country, 2023
• Figure 6 : European Commercial Amino Acids Market Share, by Country, 2023
• Figure 7 : Asia-Pacific Commercial Amino Acids Market Share, by Country, 2023
• Figure 8 : LATAM Commercial Amino Acids Market Share, by Country, 2023
• Figure 9 : Global Market Shares of Recombinant Proteins, by Region, 2023
• Figure 10 : Basic Steps Involved in Recombinant Protein Production
• Figure 11 : Snapshot of the Market Dynamics of Recombinant Proteins
• Figure 12 : Global Biopharmaceutical R&D Expenditures, 2020-2026
• Figure 13 : Applications of Recombinant Antibodies
• Figure 14 : Advantages and Disadvantages of Continuous Manufacturing
• Figure 15 : Global Market Shares of Recombinant Proteins, by Product Type, 2023
• Figure 16 : Advantages of Recombinant Antibodies
• Figure 17 : Global Market Shares of Recombinant Proteins, by Host Cell Type, 2023
• Figure 18 : Global Market Shares of Recombinant Proteins, by Application, 2023
• Figure 19 : North American Market Shares of Recombinant Proteins, by Country, 2023
• Figure 20 : European Market Shares of Recombinant Proteins, by Country, 2023
• Figure 21 : Asia-Pacific Market Shares of Recombinant Proteins, by Country, 2023
• Figure 22 : Key ESG Metrics of Recombinant Protein Companies
• Figure 23 : Global Market Shares of Oligonucleotides, by Region, 2022
• Figure 24 : Classification of Synthetic Oligonucleotides
• Figure 25 : Dynamics of the Global Market for Oligonucleotides
• Figure 26 : Global Market Shares of Oligonucleotide Synthesis, by Product Type, 2022
• Figure 27 : Global Market Shares of Oligonucleotide Synthesis, by Application, 2022
• Figure 28 : North American Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 29 : European Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 30 : Asia-Pacific Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 31 : How a Strong ESG Proposition Benefits Businesses
• Figure 32 : ESG Adoption Level across Industries, 2021 and 2022
• Figure 33 : Advantages of Protein PEGylation
• Figure 34 : Timeline of PEGylated Protein Therapeutics
• Figure 35 : Disadvantages of PEGylated Protein Therapeutics
• Figure 36 : Market Dynamics of Global PEGylated Proteins
• Figure 37 : Emerging Technologies in the PEGylated Proteins Market
• Figure 38 : Global Market Shares of PEGylated Proteins, by Protein Type, 2022
• Figure 39 : Global Market Shares of PEGylated Proteins, by PEGylation Type, 2022
• Figure 40 : Global Market Shares of PEGylated Proteins, by Application, 2022
• Figure 41 : Global Market Shares of PEGylated Proteins, by Region, 2022
• Figure 42 : North American Market Shares of PEGylated Proteins, by Country, 2022
• Figure 43 : European Market Shares of PEGylated Proteins, by Country, 2022
• Figure 44 : Asia-Pacific Market Shares of PEGylated Proteins, by Country, 2022
• Figure 45 : Snapshot of ESG Pillars
• Figure 46 : Advantages of ESG for Companies
• Figure 47 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 48 : Trends in Peptide Therapeutics Manufacturing
• Figure 49 : Snapshot of the Market Dynamics for Peptide Synthesis
• Figure 50 : India's Biotechnology Sectoral Thrust
• Figure 51 : Global Projected Incidence of Diabetes, Patients Aged 20-79 Years, 2010 and 2030
• Figure 52 : Global Infectious Disease Outbreaks, 2020 to 2022
• Figure 53 : Global Infectious Disease Outbreak, 2022
• Figure 54 : Snapshot: Key Trends in Peptide Drugs and Therapeutics Technologies
• Figure 55 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 56 : Global Market Shares of Peptide Synthesis, by Application, 2022
• Figure 57 : Global Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 58 : Global Market Shares of Peptide Synthesis, by Region, 2022
• Figure 59 : North American Market Shares of Peptide Synthesis, by Application, 2022
• Figure 60 : North American Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 61 : North American Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 62 : North American Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 63 : North American Market Shares of Peptide Synthesis, by Country, 2022
• Figure 64 : European Market Shares of Peptide Synthesis, by Application, 2022
• Figure 65 : European Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 66 : European Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 67 : European Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 68 : European Market Shares of Peptide Synthesis, by Country, 2022
• Figure 69 : Asia-Pacific Market Shares of Peptide Synthesis, by Application, 2022
• Figure 70 : Asia-Pacific Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 71 : Asia-Pacific Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 72 : Asia-Pacific Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 73 : Asia-Pacific Market Shares of Peptide Synthesis, by Country, 2022
• Figure 74 : RoW Market Shares of Peptide Synthesis, by Application, 2022
• Figure 75 : RoW Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 76 : RoW Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 77 : RoW Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 78 : RoW Market Shares of Peptide Synthesis, by Country/Region, 2022
• Figure 79 : Snapshot: Key ESG Trends in Peptide Therapeutics Industry

The global market for commercial amino acids is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.

The global market for recombinant proteins is expected to grow from $141.8 billion in 2024 to $203.6 billion by 2029, at a CAGR of 7.5% from 2024 through 2029.

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 to $15.9 billion by 2028, at a CAGR of 9.4% from 2023 through 2028.

Research Review Scope

Protein synthesis is vital for all living organisms, enabling cells to produce the proteins they need to survive and function. It is a basic biological process that builds proteins in cells, which is essential for every cellular function. The key components of protein synthesis are Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), ribosomes, and amino acids.

The growing demand for protein therapeutics due to the increase in the prevalence of chronic diseases is a major factor driving this market. Advances in cell-free systems and improved expression vectors, which enhance efficiency and productivity, also help to boost the protein synthesis market. The developments towards cell-free systems, high-throughput technologies, and a focus on personalized medicine also act as key factors for the growth of the protein synthesis market. The high production costs and complex techniques affect the growth of the market.

The market includes major players such as Amgen Inc., Pfizer Inc., Genentech, USA Inc., and Eli Lilly, which mainly focus on protein therapeutics. The companies focusing on protein synthesis research and development include GenScript ProBio, Aldevron, Creative Biogene, and Tierra Biosciences Inc.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of protein-synthesis provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO007N Commercial Amino Acids.
• BIO254A Global Recombinant Proteins Market.
• BIO220B Oligonucleotides: Global Markets.
• BIO253A PEGylated Proteins Market.
• BIO252A Peptide Synthesis: Global Markets.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Commercial Amino Acids (BIO007N)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Commercial Interests
• Chemical Structure
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Challenges
• Market Opportunity
• Regulatory Structure
• Global Regulatory Framework
• Regulatory Requirements for Different Applications
• Quality Control and Manufacturing Standards
• Emerging Technologies and Developments
• Metabolic Engineering and Synthetic Biology
• High-throughput Screening and Fermentation Optimization
• Continuous-Flow Biocatalysis
• Advanced Chromatography Techniques
• Hydroxy Amino Acids
• Green Chemistry and Sustainable Production
• Key Market Trends
• Commercial Amino Acids: Global Markets
• Commercial Amino Acids Market, by Product Type
• Methionine
• Lysine
• Threonine
• Tryptophan
• Phenylalanine
• Glutamic Acid
• Cysteine
• Aspartic Acid
• Glycine
• Alanine
• Arginine
• Proline
• Leucine
• Valine
• Tyrosine
• Other Amino Acids
• Commercial Amino Acids Market, by Application
• Animal Feed Applications
• Food Flavoring Applications
• Specialty Uses Applications
• Commercial Amino Acids Market, by Region
• North America
• Europe
• Asia-Pacific
• LATAM
• Rest of the World
• Sustainability in Commercial Amino Acids: An ESG Perspective
• Introduction to ESG
• Sustainability in the Commercial Amino Acids Market
• Understanding the ESG Data

Chapter 3 Global Recombinant Proteins Market (BIO254A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Types of Expression Host Systems
• Mechanism of Action of Recombinant Proteins
• Common Steps Involved in Recombinant Protein Production
• Market Dynamics of Recombinant Proteins
• Drivers
• Restraints
• Opportunities
• Emerging Technologies and Developments in Recombinant Proteins
• Protein-Engineering Advances
• CRISPR Genome Editing
• Cell-Free Protein Synthesis
• Global Market for Recombinant Proteins, by Product Type
• Hormones
• Cytokines
• Enzymes
• Antibodies
• Antigens
• Others
• Global Market for Recombinant Proteins, by Host Cell Type
• Bacterial Host Cells
• Yeast and Fungi Cells
• Mammalian Cells
• Insect Cells
• Other Cells
• Global Market for Recombinant Proteins, by Application
• Therapeutics and Vaccines
• Biomedical Research
• Diagnostics
• Global Market for Recombinant Proteins, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Recombinant Proteins Market
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 4 Oligonucleotides: Global Markets (BIO220B)

• Market Outlook
• Scope of Report
• Market Insights
• Market Overview
• History of Oligonucleotide Synthesis
• Types of Oligonucleotides
• Alternative Forms of Oligonucleotide Synthesis
• Versatile Functions of Synthetic Oligonucleotides
• Regulatory Paths for Oligotherapeutics
• Animal Models and Studies
• Role of Regulatory Authorities
• Global Market Dynamics for Oligonucleotides
• Market Drivers
• Market Restraints
• Opportunities in the Market
• Emerging Applications in Various Fields
• Emerging Technologies and Developments in Oligonucleotides
• DNA Synthesizers
• Emerging Technologies
• Global Market for Oligonucleotide Synthesis, by Product Type
• Oligonucleotide Drugs
• Equipment and Reagents
• Synthesized Oligos
• Services
• Global Market for Oligonucleotide Synthesis, by Application
• Research
• Diagnostics and Therapeutics
• Global Market for Oligonucleotide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Developments in the Oligonucleotide Market
• Introduction to ESG
• Assessing the Sustainability of the Oligonucleotide Manufacturing Process
• ESG Performance in Market
• Concluding Remarks

Chapter 5 PEGylated Proteins Market (BIO253A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Advantages of Protein PEGylation
• Limitations of PEGylated Therapeutics
• Market Dynamics for the PEGylated Proteins
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Non-Covalent PEGylation
• PEGylation of Nanoparticles
• Antibody-Drug Conjugates (ADCs)
• Global PEGylated Proteins Market, by Protein Type
• Granulocyte-Colony Stimulating Factors (G-CSF)
• PEGylated Monoclonal Antibodies
• PEGylated Interferons
• PEGylated Recombinant Factors
• Other Protein Types
• Global PEGylated Proteins Market, by PEGylation Type
• Linear PEGylated Proteins
• Branched PEGylated Proteins
• Global PEGylated Proteins Market, by PEGylation Application
• Autoimmune Diseases
• Hematology
• Cancer
• Other Applications
• Global PEGylated Proteins Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in PEGylated Proteins Market: ESG Perspective
• Introduction to ESG
• Sustainability in the PEGylated Proteins Industry
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 6 Peptide Synthesis: Global Markets (BIO252A)

• Market Outlook
• Scope of Report
• Market Summary
• Peptide Therapeutics Market Overview
• Importance of Peptides
• Peptide Synthesis
• Trends in Peptide Therapeutics
• Market Dynamics
• Market Drivers
• Market Restraint
• Market Opportunities
• Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing
• Advances in SPPS in Aqueous Media
• Chemical Synthesis
• Peptide Drug Delivery
• Examples of New Developments, by Company
• Market Analysis, by Segment
• Global Market for Peptide Synthesis, by Peptide Type
• Synthetic Peptides
• Antimicrobial Peptides
• Hormonal Peptides
• Bioactive Peptides
• Collagen Peptides
• Other Products
• Global Market for Peptide Synthesis, by Application
• Peptide Therapeutics
• Cosmetics
• Nutraceuticals
• Other Applications
• Global Market for Peptide Synthesis, by Synthesis Type
• Solid-phase
• Solution-phase
• Hybrid-phase
• Global Market for Peptide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Peptide Synthesis Industry: ESG Perspective
• Importance of ESG among Peptide Therapeutics Manufacturers
• ESG Practices of Peptide Therapeutics Manufacturers
• BCC Research Viewpoint

Chapter 7 Appendix

• Research Methodology
• Analyst's Credentials